Categories Article Clinical trials Phase II Studies Toxicity Year 2021 Accelerator-based BNCT for patients with recurrent glioblastoma: a multicenter phase II study Post author By ISNCT Post date May 20, 2022 Neurooncology Advances, 2021 Tags Goto H, Hirose K., Kato T., Kawabata S., Miyatake S., Narita Y, Neurooncology Advances, Suzuki M., Tanaka H.
ISNCTISNCT